ResearcherSun Yat-sen UniversityActive in the last 2 years

Rui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0604-1770; OpenAlex author ID A5013967106. Sources: OpenAlex.

Their work

Papers: 5 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 20

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper

Papers 5

KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progression. Co-author DOI 10.1158/0008-5472.can-24-0927 ↗
CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. Co-author DOI 10.1038/s41467-023-41861-y ↗
Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41588-023-01568-8 ↗
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-22-3346 ↗
Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Co-author DOI 10.1186/s13073-021-01002-w ↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jian Zheng · 5 shared papers, 2021–2024 · strength 0.68
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Xudong Huang · 5 shared papers, 2021–2024 · strength 0.68
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Jialiang Zhang · 5 shared papers, 2021–2024 · strength 0.68
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Dongxin Lin · 5 shared papers, 2021–2024 · strength 0.68
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Quanbo Zhou · 4 shared papers, 2023–2024 · strength 0.58
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Lingxing Zeng · 4 shared papers, 2023–2024 · strength 0.58
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Shaoping Zhang · 4 shared papers, 2023–2024 · strength 0.58
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Rufu Chen · 4 shared papers, 2021–2024 · strength 0.54
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Jiachun Su · 4 shared papers, 2021–2023 · strength 0.52
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Zhixiang Zuo · 3 shared papers, 2021–2023 · strength 0.38
- Paper Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarc… DOI 10.1038/s41588-023-01568-8 ↗
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗
Ziming Chen · 2 shared papers, 2023–2024 · strength 0.29
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Xiaowei He · 2 shared papers, 2023–2024 · strength 0.29
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Zilan Xu · 2 shared papers, 2023–2024 · strength 0.29
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Chunling Xue · 2 shared papers, 2023–2024 · strength 0.29
- Paper KHSRP Stabilizes m6A-Modified Transcripts to Activate FAK Signaling and Promote Pancreatic Ductal Adenocarcinoma Progre… DOI 10.1158/0008-5472.can-24-0927 ↗
- Paper N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-3346 ↗
Yanfen Zheng · 2 shared papers, 2021–2023 · strength 0.24
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗
Ying Ye · 2 shared papers, 2021–2023 · strength 0.24
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗
Rufu Chen · 1 shared paper, 2023 · strength 0.14
- Paper CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. DOI 10.1038/s41467-023-41861-y ↗
Lusheng Wei · 1 shared paper, 2021 · strength 0.10
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗
Junge Deng · 1 shared paper, 2021 · strength 0.10
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗
Ling Pan · 1 shared paper, 2021 · strength 0.10
- Paper Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. DOI 10.1186/s13073-021-01002-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.